See every side of every news story
Published loading...Updated

Efficacy and Safety of Xanomeline/Trospium Chloride and Experience in Treating Schizophrenia

Panelists discuss how real-world experience with xanomeline/trospium chloride shows efficacy across all 3 symptom domains with manageable gastrointestinal adverse effects that typically resolve within 2 weeks, requiring slow titration and patient education about empty stomach dosing.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

psychiatrictimes.com broke the news in on Monday, August 4, 2025.
Sources are mostly out of (0)